Ki-67 Labeling Index AI
Assessment in immunohistochemical specimens
Research/DevelopmentPublished (Diagnostics, 2026)
Key Facts
Indication
Assessment in immunohistochemical specimens
Phase
Research/Development
Status
Published (Diagnostics, 2026)
Company
About Medmain
Medmain develops and operates PidPort, an AI-powered analytical system for pathological image diagnosis and remote telepathology services.
View full company profile